The Effects of Antibiotic Exposure in Early Infancy on Vaccine Responses
NCT06079606 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-12-18
Summary
This prospective cohort study will include 200 term children born in Landspitali University Hospital in Iceland. The cohort will be divided into four groups according to antibiotic exposure of which one is the control group. Children's immune responses to live oral rotavirus vaccine as well as conventional vaccinations given at three, five and 12 months old will be determined by measuring salivary and serologic responses. Responses will be compared between the four groups. Stool samples will also be collected from participants and the composition of the microbiome compared between the four groups.
Conditions
- Immune Responses
- Antibiotic Treatment
Interventions
- OTHER
-
Antibiotic treatment
Children will be assigned to groups according to antibiotic exposure in early life. No antibiotics will be given in the study.
Sponsors & Collaborators
-
Landspitali University Hospital
lead OTHER
Eligibility
- Max Age
- 6 Weeks
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-09-10
- Primary Completion
- 2025-02-28
- Completion
- 2027-12-31
Countries
- Iceland
Study Locations
More Related Trials
-
Dynamics of the Microbiome in the Premature Infant
NCT02121938 ·Status: COMPLETED
-
Ancillary Microbiome Collection From Mother/Infant Pairs During First Year of Life
NCT03236194 ·Status: COMPLETED
-
COVID Booster in Pregnancy and Lactation
NCT05543993 ·Status: COMPLETED
-
Pilot Study - Monitoring the Nasal Microbiome and Viral Respiratory Infections in Newborn Hospitalized in Neonatalogy.
NCT06389383 ·Status: COMPLETED ·Phase: NA
-
Restoration of Antibiotics Related Infant Microbiota Perturbations by Autologous Fecal Transplant
NCT06609980 ·Status: RECRUITING ·Phase: PHASE1
-
Immune Health Biomarkers and Fecal Microbiota in Filipino Breastfed Infants
NCT06708559 ·Status: ACTIVE_NOT_RECRUITING
-
Prenatal Antibiotics and Breast Milk / Neonatal IgA
NCT05813184 ·Status: RECRUITING
-
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
NCT03246230 ·Status: COMPLETED ·Phase: NA
-
The Investigation of Methods to Capture Acute Respiratory and Gastrointestinal Infections of Children Aged 1 to 3 Years
NCT02081833 ·Status: COMPLETED
-
Lactamica 9: Neisseria Lactamica Inoculation in Late Pregnancy
NCT04784845 ·Status: COMPLETED ·Phase: NA
-
Infant Immune Response to Bacterial Infection
NCT00546195 ·Status: COMPLETED
-
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
NCT06283355 ·Status: RECRUITING ·Phase: PHASE1
-
Paediatric European Group A Streptococcal United Study.
NCT06058117 ·Status: RECRUITING
-
Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
NCT05244967 ·Status: RECRUITING
-
Immune Response Induced by a Vaccine Against Group B Streptococcus and Safety in Pregnant Women and Their Offsprings
NCT01446289 ·Status: COMPLETED ·Phase: PHASE2
-
Antimicrobial PK in Infants With Suspected or Confirmed Infection
NCT00491426 ·Status: COMPLETED
-
Effects of IAP-EOGBSD on Offspring's Gut Microbiome and Immunity.
NCT05738460 ·Status: UNKNOWN
-
Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial
NCT03925480 ·Status: COMPLETED ·Phase: PHASE3
-
CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice
NCT05195866 ·Status: COMPLETED ·Phase: NA
-
Paediatric Infections Point-Of-Care
NCT03900091 ·Status: COMPLETED
-
Antibiotic-induced Disruption of the Microbiota
NCT04091282 ·Status: RECRUITING
-
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533 ·Status: COMPLETED ·Phase: NA
-
Molecular Culture for the Diagnosis of Pediatric Sepsis
NCT06018792 ·Status: RECRUITING
-
Maternal Immunization: Giving Immunity For Tomorrow
NCT01496079 ·Status: COMPLETED
-
Role of Oral Lactoferrin in Prevention of Recurnt Bacterial Vaginosis in Pregnancy
NCT05669963 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3